COVID-19 Vaccine Contenders Race Against the Clock, and Each Other

Oxford University’s coronavirus vaccine gets significant financial backing and promises possible September vaccine delivery. China and Canada teamed up on the first human testing of a vaccine, and initial results are positive. Moderna’s recent vaccination tests were small in number but sent the stock market soaring. In the race to find a COVID-19 vaccine, hope …

3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet

AstraZeneca has announced that it will be distributing 400 million doses of Oxford University’s coronavirus vaccine from September. However, there are at least three reasons to suspect that the coronavirus vaccine may not work. No coronavirus vaccine has ever been produced, immunity may be short-lived, and it may actually take anything from five to ten …

This S&P 500 Stock Is Surprisingly the Best Performer This Year

One pharmaceutical company is outperforming all S&P 500 stocks. Regeneron has made a massive surge over the last three months as the company continues to develop a possible COVID-19 treatment. Equity analysts believe that the stock has more upside potential. While popular COVID-19 bets such as Amazon (NASDAQ:AMZN) and Netflix (NASDAQ:NFLX) have taken center stage, …